MEDIUM · 6.1

CVE-2026-1037

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embe...

Vulnerability Description

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

CVSS Score

6.1

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
REQUIRED
Scope
CHANGED
Confidentiality
LOW
Integrity
LOW
Availability
NONE

Related Weaknesses (CWE)

References

FAQ

What is CVE-2026-1037?

CVE-2026-1037 is a vulnerability with a CVSS score of 6.1 (MEDIUM). IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embe...

How severe is CVE-2026-1037?

CVE-2026-1037 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-1037?

Check the references section above for vendor advisories and patch information. Review vendor security bulletins for remediation guidance.